Spegra (Spegra) 90 tab. Tenofovir Alafenamide 25 mg, Emtricitabine 200 mg, Dolutegravir 50 mg. A drug for the treatment of HIV infection.Spegra tablets (dolutegravir (50 mg) + emtricitabine (200 mg) + tenofovir alafenamide (25 mg)) does not cure HIV, but slows down the growth of the virus in the body. It is a combination drug used to treat HIV. HIV is spread through unclean blood, semen and vaginal fluid.
Spegra contains three active ingredients: dolutegravir, emtricitabine, tenofovir alafenamide. Spegra is used to treat type 1 HIV infection by suppressing the growth of copies of the HIV virus, which leads to an increase in the level of immune T cells. Spegra is a second-generation HIV integrase inhibitor. Spegra is the latest antiretroviral drug used to treat HIV infection.
Contraindications
Spegra is contraindicated in patients who are simultaneously receiving Elbasvir and Grazoprevir. Hypersensitivity reactions occur in patients who are contraindicated by one of the components of Spegra.
Skipping an appointment
Spegra is a combination of three drugs, care should be taken during therapy with Spegra. Please consult your doctor. Follow a regular schedule of taking the drug. Avoid skipping the drug if possible. Do not take medications on your own.
Side effects
Nausea
Fatigue
Abdominal pain
vomiting
Decrease in the number of platelets
Increased serum creatinine
diarrhea
Upper Respiratory Tract Infection
Rare Side Effects from Spegra:
Heartburn
Skin rash
Back pain
Taste changes
Cough
swelling
Dizziness
Safety precautions
Resistance
Spegra is a combination of three drugs with a fixed dosage; there is a possibility of resistance. Monitor the patient's viral load status according to the regulations.
The nervous system
Reduce the load on the central nervous system by taking Spegra before going to bed on an empty stomach.
Effect on the fetal embryo
Spegra is contraindicated during pregnancy
Skin problems
Severe hypersensitivity reactions occur during Spegra therapy. Providing general support measures will prevent the problem.